Security record · archived quarter
HLN
Haleon plc · Healthcare · Drug Manufacturers - Specialty & Generic
3Tracked holders
0Δ holders
156.92KShares held
$1.42MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 156.92K | $1.42M | n/a | n/a |
| Q2 2026 | 105 | +5 | 532.53M | $4.91B | +8 | −2 |
| Q1 2026 | 100 | +1 | 506.60M | $5.01B | +6 | −6 |
| Q4 2025 | 99 | -2 | 494.67M | $4.94B | +1 | −2 |
| Q3 2025 | 16 | -1 | 341.18M | $3.06B | +1 | −3 |
| Q2 2025 | 15 | 0 | 306.18M | $3.18B | +2 | −2 |
| Q1 2025 | 13 | 0 | 210.33M | $2.16B | n/a | n/a |
| Q4 2024 | 13 | +1 | 208.23M | $1.99B | +2 | −1 |
| Q3 2024 | 11 | 0 | 206.41M | $2.18B | +2 | −2 |
| Q2 2024 | 11 | n/a | 210.64M | $1.74B | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wealth Enhancement Advisory… | 85.54K | +1.6% | $792,120 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | TD Waterhouse Canada Inc. | 56.99K | +336.0% | $497,100 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Assetmark, Inc | 14.38K | +89.6% | $129,459 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 618 holders, 559.47M shares, $5.40B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API